151 related articles for article (PubMed ID: 12831361)
1. Progress and challenges for cell encapsulation in brain tumour therapy.
Visted T; Lund-Johansen M
Expert Opin Biol Ther; 2003 Jul; 3(4):551-61. PubMed ID: 12831361
[TBL] [Abstract][Full Text] [Related]
2. Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors.
Bhujbal SV; de Vos P; Niclou SP
Adv Drug Deliv Rev; 2014 Apr; 67-68():142-53. PubMed ID: 24491927
[TBL] [Abstract][Full Text] [Related]
3. Cell encapsulation technology as a therapeutic strategy for CNS malignancies.
Visted T; Bjerkvig R; Enger PO
Neuro Oncol; 2001 Jul; 3(3):201-10. PubMed ID: 11465401
[TBL] [Abstract][Full Text] [Related]
4. Cell therapy using encapsulated cells producing endostatin.
Bjerkvig R; Read TA; Vajkoczy P; Aebischer P; Pralong W; Platt S; Melvik JE; Hagen A; Dornish M
Acta Neurochir Suppl; 2003; 88():137-41. PubMed ID: 14531571
[TBL] [Abstract][Full Text] [Related]
5. Local endostatin treatment of gliomas administered by microencapsulated producer cells.
Read TA; Sorensen DR; Mahesparan R; Enger PO; Timpl R; Olsen BR; Hjelstuen MH; Haraldseth O; Bjerkvig R
Nat Biotechnol; 2001 Jan; 19(1):29-34. PubMed ID: 11135548
[TBL] [Abstract][Full Text] [Related]
6. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.
Joki T; Machluf M; Atala A; Zhu J; Seyfried NT; Dunn IF; Abe T; Carroll RS; Black PM
Nat Biotechnol; 2001 Jan; 19(1):35-9. PubMed ID: 11135549
[TBL] [Abstract][Full Text] [Related]
7. Alginate-encapsulated producer cells: a potential new approach for the treatment of malignant brain tumors.
Thorsen F; Read TA; Lund-Johansen M; Tysnes BB; Bjerkvig R
Cell Transplant; 2000; 9(6):773-83. PubMed ID: 11202564
[TBL] [Abstract][Full Text] [Related]
8. The development of encapsulated cell technologies as therapies for neurological and sensory diseases.
Zanin MP; Pettingill LN; Harvey AR; Emerich DF; Thanos CG; Shepherd RK
J Control Release; 2012 May; 160(1):3-13. PubMed ID: 22285549
[TBL] [Abstract][Full Text] [Related]
9. A perspective on bioactive cell microencapsulation.
Acarregui A; Murua A; Pedraz JL; Orive G; Hernández RM
BioDrugs; 2012 Oct; 26(5):283-301. PubMed ID: 22715813
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation in Cell Therapy: Methodologies, Materials, and Clinical Applications.
Galvez-Martín P; Martin JM; Ruiz AM; Clares B
Curr Pharm Biotechnol; 2017; 18(5):365-377. PubMed ID: 28464772
[TBL] [Abstract][Full Text] [Related]
11. Historical Perspectives and Current Challenges in Cell Microencapsulation.
de Vos P
Methods Mol Biol; 2017; 1479():3-21. PubMed ID: 27738923
[TBL] [Abstract][Full Text] [Related]
12. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
13. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
[TBL] [Abstract][Full Text] [Related]
14. CellMAC: a novel technology for encapsulation of mammalian cells in cellulose sulfate/pDADMAC capsules assembled on a transient alginate/Ca2+ scaffold.
Weber W; Rinderknecht M; Daoud-El Baba M; de Glutz FN; Aubel D; Fussenegger M
J Biotechnol; 2004 Nov; 114(3):315-26. PubMed ID: 15522441
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.
Husain SR; Puri RK
J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic applications of encapsulated cells.
Acarregui A; Orive G; Pedraz JL; Hernández RM
Methods Mol Biol; 2013; 1051():349-64. PubMed ID: 23934816
[TBL] [Abstract][Full Text] [Related]
17. Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes.
Tseng YY; Su CH; Yang ST; Huang YC; Lee WH; Wang YC; Liu SC; Liu SJ
Oncotarget; 2016 Sep; 7(37):59902-59916. PubMed ID: 27494894
[TBL] [Abstract][Full Text] [Related]
18. History, challenges and perspectives of cell microencapsulation.
Orive G; Hernández RM; Rodríguez Gascón A; Calafiore R; Chang TM; de Vos P; Hortelano G; Hunkeler D; Lacík I; Pedraz JL
Trends Biotechnol; 2004 Feb; 22(2):87-92. PubMed ID: 14757043
[TBL] [Abstract][Full Text] [Related]
19. Update on immunoisolation cell therapy for CNS diseases.
Emerich DF; Salzberg HC
Cell Transplant; 2001; 10(1):3-24. PubMed ID: 11294469
[TBL] [Abstract][Full Text] [Related]
20. Cell therapies in neuro-oncology.
Pellegatta S; Finocchiaro G
Neurol Sci; 2005 May; 26 Suppl 1():S43-5. PubMed ID: 15883693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
